| Literature DB >> 29263601 |
Pratik Ramesh Wankhade1, A Manimaran1, A Kumaresan1, S Jeyakumar1, K P Ramesha2, V Sejian3, D Rajendran4, Minu Rachel Varghese5.
Abstract
Smooth transition from pregnancy to lactation is important for high productive and reproductive performance during later postpartum period in dairy animals. On the other hand, the poor transition often leads to huge economic loss to dairy farmers due to compromised production and reproduction. Therefore, understanding the causes and consequence of metabolic changes during the transition period is very important for postpartum health management. In this review, metabolic changes with reference to negative energy balance in transition cow and its effect on health and reproduction during the later postpartum period in dairy animals are discussed besides the role of metabolic inflammation in postpartum performance in dairy animals.Entities:
Keywords: acute phase proteins; dairy cows; inflammatory cytokines; negative energy balance; transition period
Year: 2017 PMID: 29263601 PMCID: PMC5732345 DOI: 10.14202/vetworld.2017.1367-1377
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Figure-1Interaction between growth hormone (GH) and insulin in postpartum dairy cows. Solid lines indicate stimulatory actions, while broken lines infer negative feedback or inhibitory actions. IR: Insulin receptor, GHR: GH receptor [12].
a. Reported associations between pre- and post-partum NEFA concentrations and postpartum disease risk in dairy animals.
| Cut points | Time | Disease | Risk factor/risk ratio | References |
|---|---|---|---|---|
| <0.5-2 mM | Last week before calving | NS | NS | [ |
| 0.5-1 mM | Last week before calving | NS | NS | [ |
| ≥0.37 mmol/l | −14 to−2 days | RFM | 2.4 | [ |
| ≥0.38 mmol/l | −14 to−2 days | RFM or Met | 2.1 | [ |
| ≥0.29 mmol/l | −14 to−2 days | Any disease | 1.6 | [ |
| ≥0.36 mmol/l | +3 to 14 days | RFM or Met | 13.2 | [ |
| ≥0.57 mmol/l | +3 to 14 days | Any disease | 1.9 | [ |
| ≥0.4 mmol/l | −21 to−3 days | Any disease | 4.1 | [ |
| ≥0.5 mmol/l | −21 to−3 days | Any disease | 4.2 | [ |
| ≥0.6 mmol/l | −21 to−3 days | Any disease | 6.4 | [ |
| ≥0.5 mmol/l | +3 to 21 days | Any disease | 2.1 | [ |
| ≥0.6 mmol/l | +3 to 21 days | Any disease | 5.0 | [ |
| ≥0.7 mmol/l | +3 to 21 days | Any disease | 7.1 | [ |
| ≥0.3 mmol/l | −1 week | RFM | 1.6 | [ |
| 0.29 mEq/L | Prepartum | DA, CK, Met and RFM, or any of these three | NS | [ |
| 0.26 mEq/L | Prepartum | CK | 1.8 | [ |
| 0.37 mEq/L | Prepartum | Met, RFM, or both | 2.2 | [ |
| 0.57 mEq/L | Postpartum | DA, CK, and Met and RFM, or any of these three | 4.4 | [ |
| 0.57 mEq/L | Postpartum | CK | 5.0 | [ |
| 0.36 mEq/L | Postpartum | Met, RP, or both | 17 | [ |
| ≥0.72 mEq/L | Postpartum | Decreased milk yield | NS | [ |
| >0.4 mmol/L | 7-10 days before calving | Increased risk of DA, RFM, Culling before 60 days in milk, less milk production in first 4 months of lactation | NS | [ |
| 0.3 mmol/L | 1 week before calving | CE and SCE | 9.1 and 12.1 | [ |
| 0.84±0.06 mmol/L | 12-24 h after calving | RFM | NS | [ |
| ≥0.5 mEq/L | 1 week before calving | Only in multiparous cows, 3.0±1.5 kg/day per cow milk loss and odds of pregnancy at first AI were lower | NS | [ |
| ≥1.0 mEq/L | +1 week of calving | Odds of pregnancy at first AI were lower | NS | [ |
| >400 mmol/L | Up to postpartum 6 weeks | Ketosis | NS | [ |
| 0.74±0.29 mmol/L | −5 days | Clinically healthy | NS | [ |
| 1.08±0.51 mmol/L | 5 days | Clinically healthy | NS | [ |
| 0.76±0.43 mmol/L | 10 days | Clinically healthy | NS | [ |
| 0.35±0.19 mmol/L | 30 days | Clinically healthy | NS | [ |
| 0.15±0.10 mmol/L | 60 days | Clinically healthy | NS | [ |
| b. Reported associations between pre- and post-partum BHBA concentrations and postpartum disease risk in dairy animals | ||||
| ≥670 mmol/l | 3-14 days | Met | 1.5 | [ |
| ≥960 mmol/l | 3-14 days | Any disease | 3.1 | [ |
| ≥960 mmol/l | 3-21 days | Any disease | 2.8 | [ |
| ≥1150 mmol/l | 3-21 days | Any disease | 3.5 | [ |
| ≥1340 mmol/l | 3-21 days | Any disease | 4.2 | [ |
| ≥1536 mmol/l | 3-21 days | Any disease | 5.6 | [ |
| ≥1728 mmol/l | 3-21 days | Any disease | 6.5 | [ |
| ≥1920 mmol/l | 3-21 days | Any disease | 5.0 | [ |
| ≥1200 mmol/l | 1-7 days | Met | 3.35 | [ |
| ≥1400 mmol/L | 1-2 weeks after calving | Subclinical ketosis | NS | [ |
| ≥1100 mmol/L | Postpartum period | SCE | NS | [ |
| 10 mg/dL | Postpartum | DA, CK, Met and RFM, or any of these three | 4.4 | [ |
| 10 mg/dL | Postpartum | CK | 4.9 | [ |
| 7 mg/dL | Postpartum | Met, RFM, or both | 2.3 | [ |
| 10 mg/dL | Postpartum | Decreased milk yield | NS | [ |
| >1200-1400 mmol/L | 1-2 week after calving | Increased risk of DA, Met, endometritis, ketosis, prolonged uterine anovulation, increased severity of mastitis, lower milk production in early lactation | NS | [ |
| 0.51±0.08 mmol/L | 12-24 hrs after calving | RFM | NS | [ |
| ≥800 mmol/L | −1 week of calving | Associated with milk loss of 4.4±1.7 kg/day per cow | NS | [ |
| 0.81±0.27 mmol/L | −5 days | Clinically healthy | NS | [ |
| 1.29±0.37 mmol/L | 5 days | Clinically healthy | NS | [ |
| 1.03±0.43 mmol/L | 10 days | Clinically healthy | NS | [ |
| 0.80±0.24 mmol/L | 30 days | Clinically healthy | NS | [ |
| 0.66±0.21 mmol/L | 60 days | Clinically healthy | NS | [ |
| ≥670 mmol/l | 3-14 days | Met | 1.5 | [ |
NS=Not specified; days with negative symbol indicates before calving, while days with positive symbol indicate after calving. Met=Metritis, RFM=Retained fetal membranes, DA=Displaced abomasum, CK=Clinical ketosis, CE=Clinical endometritis, SCE=Subclinical endometritis, NEFA=Non-esterified fatty acid, BHBA=Beta-hydroxybutyric acid
Figure-2Suggested mechanism for liver-related periparturient metabolic disorders in dairy cows [72].